Benzinga's Top Initiations
- Analysts at Goldman Sachs initiated coverage on Cal-Maine Foods Inc (NASDAQ: CALM) with a Neutral rating. The price target for Cal-Maine is set to $37. Cal-Maine shares closed at $38.05 on Wednesday.
- B. Riley initiated coverage on CTS Corporation (NYSE: CTS) with a Buy rating. The price target for CTS is set to $22. CTS shares closed at $18.80 on Wednesday.
- Analysts at Barclays initiated coverage of Mammoth Energy Services Inc (NASDAQ: TUSK) with an Overweight rating. The price target for Mammoth Energy is set to $18. Mammoth Energy shares closed at $13.41 on Wednesday.
- Analysts at Seaport Global Securities initiated coverage on Kirby Corporation (NYSE: KEX) with a Neutral rating. The price target for Kirby is set to $55. Kirby shares closed at $62.50 on Wednesday.
- Analysts at Rodman & Renshaw initiated coverage on Cellect Biotechnology Ltd. (NASDAQ: APOP) with a Buy rating. The price target for Cellect Biotechnology is set to $10. Cellect Biotechnology shares closed at $3.56 on Wednesday.
- Analysts at Deutsche Bank assumed coverage on Mondelez International Inc (NASDAQ: MDLZ) with a Hold rating. Mondelez shares closed at $44.01 on Wednesday.
- Oppenheimer initiated coverage on Yum China Holdings Inc (NYSE: YUMC) with an Outperform rating. The price target for Yum China is set to $33. Yum China shares closed at $26.00 on Wednesday.
- Analysts at Seaport Global Securities initiated coverage on Arch Coal, Inc. (NYSE: ARCH) with a Buy rating. The price target for Arch Coal is set to $95. Arch Coal shares closed at $78.99 on Wednesday.
- Analysts at Maxim Group initiated coverage on Amedica Corporation (NASDAQ: AMDA) with a Buy rating. Amedica shares closed at $0.685 on Wednesday.
Latest Ratings for CTS
Date | Firm | Action | From | To |
---|---|---|---|---|
Oct 2019 | Initiates Coverage On | Equal-Weight | ||
May 2019 | Initiates Coverage On | Outperform | ||
Nov 2016 | Initiates Coverage On | Buy |
View More Analyst Ratings for CTS
View the Latest Analyst Ratings
Posted-In: Top InitiationsInitiation Analyst Ratings
© 2019 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.